XML 48 R34.htm IDEA: XBRL DOCUMENT v3.25.1
DERIVATIVES (Tables)
3 Months Ended
Mar. 31, 2025
DERIVATIVES  
Schedule of fair values of derivative instruments on the Company's Consolidated Balance Sheets

March 31, 2025

December 31, 2024

Other

Other

Other

Other

Current

Current

Other

Other

Current

Current

Other

Other

Derivatives by hedge designation

Assets

    

Liabilities

    

Assets

    

Liabilities

    

Assets

    

Liabilities

    

Assets

    

Liabilities

Designated as hedging instruments:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Foreign exchange contracts

$

1,131

$

822

$

$

$

1,663

$

2,972

$

$

Net investment contracts

8,479

10,276

Not designated as hedging instruments:

 

Foreign exchange contracts

 

893

1,330

 

1,560

 

4,251

 

 

Total derivatives

$

2,024

$

10,631

$

$

$

13,499

$

7,223

$

$

Schedule of effects of undesignated derivative instruments on the Company's Consolidated Statements of Income

    

    

Three Months Ended March 31, 

Derivatives by hedge designation

    

Classification of gain (loss)

    

2025

    

2024

Not designated as hedges:

  

  

 

  

Foreign exchange contracts

Selling, general
& administrative expenses

$

8,333

$

(1,615)

Schedule of effects of designated cash flow hedges on AOCI and the entity's Consolidated Statements of Income

    

    

Total gain (loss) recognized in AOCI, net of tax

    

March 31, 2025

    

December 31, 2024

    

Foreign exchange contracts

$

394

$

(812)

Forward starting swap agreements

17,690

18,067

Net investment contracts

13,583

 

20,403

    

    

Three Months Ended March 31, 

(Loss) gain recognized in the

Derivative type

    

Consolidated Statements of Income:

    

2025

    

2024

Foreign exchange contracts

 

Sales

$

(713)

$

839

 

Cost of goods sold

 

361

 

232

Commodity contracts

Cost of goods sold

2

Forward starting swap agreements

Interest expense, net

689